REMEDi4ALL launched, aiming to drive forward repurposing of medicines in Europe

REMIDi4All launched yesterday with the aim of making a major leap forward in drug repurposing, Medicines for Europe, the trade body representing generics and biosimilar drugmakers, announced today.

This promising approach to drug development consisting in the identification, testing, and validation of new therapeutic indications for existing medications, is a developing field but faces numerous barriers and systemic inefficiencies.

Still, its potential to significantly bring down times and cost of drug development, it focuses on already approved, discontinued, shelved or investigational therapeutics- makes this novel strategy attractive for rare and neglected conditions, cancer, emerging public health threats such as COVID-19 or new drug combinations. It also translates into more sustainable health systems.